2022
Yann-Alexandre Vano et al.
Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial
The Lancet Oncology 2022, vol. 23, issue 5
doi: 10.1016/s1470-2045(22)00128-0
Rodrigo Nalio Ramos et al.
Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer
Cell 2022, vol. 185, issue 7
doi: 10.1016/j.cell.2022.02.021
Valérie Lorin et al.
Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller
Journal of Experimental Medicine 2022, vol. 219, issue 3
doi: 10.1084/jem.20212045
Nicolas Serafini et al.
Trained ILC3 responses promote intestinal defense
Science 2022, vol. 375, issue 6583
doi: 10.1126/science.aaz8777
Laurene Abjean et al.
Reactive astrocytes promote proteostasis in Huntington’s disease through the JAK2-STAT3 pathway
Brain 2022, vol. 146, issue 1
doi: 10.1093/brain/awac068
Sarah Temmam et al.
Bat coronaviruses related to SARS-CoV-2 and infectious for human cells
Nature 2022
doi: 10.1038/s41586-022-04532-4
Pedro Goncalves et al.
Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC-transplanted SCID patients with IL2RG/JAK3 deficiency
Blood 2022, vol. 139, issue 17
doi: 10.1182/blood.2021014654
Elmar W. Tobi et al.
Maternal Glycemic Dysregulation During Pregnancy and Neonatal Blood DNA Methylation: Meta-analyses of Epigenome-Wide Association Studies
Diabetes Care 2022, vol. 45, issue 3
doi: 10.2337/dc21-1701
Malte D. Luecken et al.
The discovAIR project: a roadmap towards the Human Lung Cell Atlas
European Respiratory Journal 2022, vol. 60, issue 2
doi: 10.1183/13993003.02057-2021
Mathieu Claireaux et al.
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry
Nature Communications 2022, vol. 13, issue 1
doi: 10.1038/s41467-022-28130-0